Tag:
Brazil
Latest Headlines
Latest Headlines
Report: Bad lifestyles fuel diagnostics boom in emerging markets
The international research outfit GlobalData sees both factors like unhealthy lifestyles as pushing the in vitro diagnostics markets in some countries to climb by 16% annually, reaching a combined $11.7 billion by 2018.
Brazil's FBM Industria licenses Ampio's quick-dissolve premature-ejaculation pill
Ampio Pharmaceuticals is taking steps to get its premature-ejaculation drug on the market around the world.
Cargo theft in Brazil violent and growing
As the 7th-largest world economy and one that has been growing at break-neck speed, Brazil is becoming a more important market for pharmaceuticals. But getting product delivered in the country can be...
Merck gains traction in Brazil with joint venture
Merck is taking closer aim at the Brazilian pharma market with a new joint venture. The U.S. company has forged a partnership with the Brazilian drugmaker Supera Farma Laboratorios, which is itself
Pharma's emerging-markets push fuels cargo growth
Over the past several years, some of the biggest stories in pharma have been international. Manufacturing moving to Asia. Outsourcing and partnerships in India. Big investments in China and Russia.
Amgen beefs up in Brazil with $215M deal
Amgen ( $AMGN ) has jumped into the Brazilian market. The U.S. company bought Bergamo, a privately held drugmaker that markets oncology drugs and other products to Brazilian hospitals, for $215
Brazilian firm nabs Mantecorp in $1.5B deal
Brazil may be a siren calling to global pharma, but it's also a hot market for domestic companies, too. Witness home-grown Hypermarcas' $1.5 billion buyout of consumer drugmaker Mantecorp Industria
Study: Brazil bests India for subject recruitment
Sponsors looking for clinical trial volunteers are better off heading south rather than east. Using systematic review and meta-analysis of data on people's willingness to participate in clinical
Drugmakers tweak their Brazilian strategies
Big Pharma is looking eastward for new growth--chiefly in China, India and Russia--but drugmakers are also moving south. The Financial Times takes a survey of drugmakers' operations and ambitions in
Pfizer picks up Brazil's Teuto in $240M deal
Pfizer will pay $240 million for a 40 percent stake in Brazil's Laboratorio Teuto Brasileiro, a generics specialist, as it expands further in emerging markets. Report
